Cara Therapeutics Inc. buy marge
Start price
18.04.17
/
50%
€15.22
Target price
21.06.17
€17.14
Performance (%)
13.75%
End price
21.06.17
€17.31
Summary
This prediction ended on 21.06.17 with a price of €17.31. The prediction had a final performance of 13.75%. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cara Therapeutics Inc. | -18.483% | -18.483% | -82.768% | -95.027% |
iShares Core DAX® | -0.530% | 2.858% | 15.472% | 17.034% |
iShares Nasdaq 100 | -0.580% | 4.871% | 28.534% | 54.277% |
iShares Nikkei 225® | -1.097% | -1.658% | 7.461% | 3.656% |
iShares S&P 500 | -0.730% | 2.647% | 24.918% | 45.236% |
Comments by marge for this prediction
In the thread Cara Therapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 18.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 19$ zu.Überschrift: Cara seems to offer a very positive risk/reward profile at current trading levels.
(Zielkurs erreicht)
Stopped prediction by marge for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.27
31.10.16
31.10.16
€20.75
17.04.17
17.04.17
146.30%
17.04.17
17.04.17